Prediction of sudden cardiac death after myocardial infarction in the beta-blocking era

Journal of the American College of Cardiology

Volumn 42, Issue 4, 2003, Pages 652-658

  Huikuri, Heikki V ^a   Tapanainen, Jari M ^a   Lindgren, Kai ^a   Raatikainen, Pekka ^a   Mäkikallio, Timo H ^a   Airaksinen, K E Juhani ^a   Myerburg, Robert J ^b  

^a UNIVERSITY OF OULU   (Finland)

^b UNIVERSITY OF MIAMI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; STATINE DERIVATIVE; WARFARIN;

ACCURACY; ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; CONTROLLED STUDY; FEMALE; HEART ARRHYTHMIA; HEART DEATH; HEART EJECTION FRACTION; HEART RATE VARIABILITY; HEART VENTRICLE TACHYCARDIA; HIGH RISK PATIENT; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRACTICE GUIDELINE; PREDICTION; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; QRS COMPLEX; QT INTERVAL; RISK ASSESSMENT; RISK FACTOR; SIGNAL AVERAGED ELECTROCARDIOGRAPHY; SUDDEN DEATH; SURVIVAL;

EID: 0041853529     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(03)00783-6     Document Type: Article

References (32)

1. Huikuri HV, Castellanos A, Myerburg RJ. Sudden death due to cardiac arrhythmias. N Engl J Med 2001;345:1473-82.
2. Myerburg RJ, Kessler KM, Castellanos A. Sudden cardiac death: epidemiology, transient risk, and intervention assessment. Ann Intern Med 1993;119:1187-97.
3. Myerburg RJ, Interian A Jr., Mitrani RM, Kessler KM, Castellanos A. Frequency of sudden cardiac death and profiles of risk. Am J Cardiol 1997;80:10-9F.
4. Michaels AD, Goldschlager N. Risk stratification after acute myocardial infarction in the reperfusion era. Prog Cardiovasc Dis 2000;42:273-309.
5. Myerburg RJ, Kessler KM, Castellanos A. Sudden cardiac death: structure, function, and time-dependence of risk. Circulation 1992;85 Suppl I:I-2-10.
6. Zipes DP, Wellens HJJ. Sudden cardiac death. Circulation 1998;98:2334-51.
7. La Rovere MT, Pinna GD, Hohnloser SH, et al. Baroreflex sensitivity and heart rate variability in the identification of patients at risk for life-threatening arrhythmias: implications for clinical trials. Circulation 2001;103:2072-7.
8. The Multicenter Postinfarction Research Group. Risk stratification and survival after myocardial infarction. N Engl J Med 1983;309:331-6.
9. Maggioni AP, Zuanetti G, Franzosi MG, et al. Prevalence and prognostic significance of ventricular arrhythmias after myocardial infarction in the fibrinolytic era: GISSI-2 results. Circulation 1993;87:312-22.
10. McClements BM, Adgey AAJ. Value of signal-averaged electrocardiography, radionuclide ventriculography, Holter monitoring and clinical variables for prediction of arrhythmic events in survivors of acute myocardial infarction in the thrombolytic era. J Am Coll Cardiol 1993;21:1419-27.
11. el-Sherif N, Denes P, Katz R, et al., the Cardiac Arrhythmia Suppression Trial/Signal-Averaged Electrocardiogram (CAST/ SAECG) Substudy Investigators. Definition of the best prediction criteria of the time domain signal-averaged electrocardiogram for serious arrhythmic events in the postinfarction period. J Am Coll Cardiol 1995;25:908-14.
12. Hartikainen JEK, Malik M, Staunton A, Poloniecki J, Camm AJ. Distinction between arrhythmic and nonarrhythmic death after acute myocardial infarction based on heart rate variability, signal-averaged electrocardiogram, ventricular arrhythmias and left ventricular ejection fraction. J Am Coll Cardiol 1996;28:296-304.
13. Glancy JM, Garratt CJ, Woods KL, de Bono DP. QT dispersion and mortality after myocardial infarction. Lancet 1995;345:945-8.
14. Perkiömäki JS, Koistinen MJ, Yli-Mäyry S, Huikuri HV. Dispersion of QT interval in patients with and without suspectibiilty to ventricular tachyarrhythmias after previous myocardial infarction. J Am Coll Cardiol 1995;26:174-9.
15. Bailey JJ, Berson AS, Handelsman H, Hodges M. Utility of current risk stratification tests for predicting major arrhythmic events after myocardial infarction. J Am Coll Cardiol 2001;38:1902-11.
16. Moss AJ, Hall WJ, Cannom DS, et al., for the Multicenter Automatic Defibrillator Implantation Trial Investigators. Improved survival with an implanted defibrillator in patients with coronary artery disease at high risk for ventricular arrhythmia. N Engl J Med 1996;335:1933-40.
17. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hofley G, the Multicenter Unsustained Tachycardia Trial Investigators. A randomized study of the prevention of sudden death in patients with coronary artery disease. N Engl J Med 1999;341:1882-90.
18. Moss AJ, Zareba W, Hall WJ, Klein H, et al., for the Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-83.
19. The MERIT-HF Study Group. Effect of metoprolol CR/XL in chronic heart failure: MEtoprolol CR/XL Randomized Intervention Trial in congestive Heart Failure (MERIT-HF). Lancet 1999;353:2001-4.
20. Tapanainen JM, Still A-M, Airaksinen KEJ, Huikuri HV. Prognostic significance of risk stratifiers of mortality, including T wave alternans, after acute myocardial infarction: results of a prospective follow-up study. J Cardiovasc Electrophysiol 2001;12:645-52.
21. Ryan TJ, Anderson JL, Braniff BA, et al. ACC/AHA guidelines for the management of patients with acute myocardial infarction: executive summary. A report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines. Circulation 1996;94:2341-50.
22. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability: standards of measurements, physiological interpretation, and clinical use. Circulation 1996;93:1043-65.
23. Breithardt G, Cain ME, El-Sherif N, et al. Standards for analysis of ventricular late potentials using high-resolution or signal-averaged electrocardiography: a statement by a Task Force Committee of the European Society of Cardiology, the American Heart Association, and the American College of Cardiology. J Am Coll Cardiol 1991;17:999-1006.
24. Niemelä MJ, Airaksinen KEJ, Huikuri HV. Effect of beta-blockade on heart rate variability in patients with coronary artery disease. J Am Coll Cardiol 1994;23:1370-7.
25. Airaksinen KEJ, Niemelä MJ, Huikuri HV. Effect of beta-blockade on baroflex sensitivity and cardiovascular autonomic function tests in patients with coronary artery disease. Eur Heart J 1994;15:1482-5.
26. Beta-blocker Heart Attack Trial (BHAT) Research Group. A randomized trial of propranolol in patients with acute myocardial infarction. JAMA 1982;247:1707-14.
27. Gottlieb SS, McCarter RJ, Vogel RA. Effect of beta-blockade on mortality among high risk and low risk patients after myocardial infarction. N Engl J Med 1996;334:1349-55.
28. Packer M, Bristow MR, Cohn JN, et al., the U.S. Carvedilol Heart Failure Study Group. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 1996;334:1349-55.
29. CIBIS-II Investigators and Committees. The Cardiac Insufficiency Bisoprolol Study II (CIBIS II): a randomized trial. Lancet 1999;353:9-13.
30. Hohnloser SH, Klingenheben T, Zabel M, Schöpperl M, Mauss O. Prevalence, characteristics and prognostic value during long-term follow-up of nonsustained ventricular tachycardia after myocardial infarction in the thrombolytic era. J Am Coll Cardiol 1999;33:1895-902.
31. Pratt CM, Greenway PS, Schoenfeld MH, et al. Exploration of the precision of classifying sudden cardiac death: implications for the interpretation of clinical trials. Circulation 1996;93:519-24.
32. Grubman EM, Pavri BB, Shipman T, et al. Cardiac death and stored electrograms in patients with third-generation implantable cardioverter-defibrillators. J Am Coll Cardiol 1998;32:1056-62.